Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Flumazenil 0.1 mg/mL Injection
Flumazenil 0.1mg/mL
Solution for injection
Max Health Limited
Hameln Pharmaceuticals GmbH, Hameln, Germany
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Trajentamet
Linagliptin 2.5mg
Metformin hydrochloride 500mg
Film coated tablet
Boehringer Ingelheim (NZ) Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Trajentamet
Linagliptin 2.5mg
Metformin hydrochloride 850mg
Film coated tablet
Boehringer Ingelheim (NZ) Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
|
|
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Trajentamet
Linagliptin 2.5mg
Metformin hydrochloride 1000mg
Film coated tablet
Boehringer Ingelheim (NZ) Ltd
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
|
Dated this 17th day of September 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz